跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tapazole - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tapazole
Approved
STANDARD
Tapazole
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
186aacf1052e6fd2
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
186aacf1052e6fd2
Drug Approval Philippines Name
Tapazole
Product Name
Tapazole
Registration Number
DR-4441
Brand Name
Tapazole
Generic Name
Thiamazole
Dosage Form
Tablet
Dosage Strength
5mg
Manufacturer
Interphil Laboratories, Inc.
Trader
A. Menarini Asia Pacific Holdings Pte. Ltd
Issuance Date
25 July 2024
Expiry Date
31 August 2029
Pharmacologic Category
Antithyroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
186aacf1052e6fd2
Type
Standard
Back to Philippines FDA Approvals